March 12, 2018
Renowned breast surgeon joins practice with more than two decades of experience, expanding the service offering to more patients Fairfax, Va. (March 12, 2018) —Virginia Cancer Specialists (VCS) announced that Hernan Vargas, MD, has joined the practice. VCS, a practice in The US Oncology Network, is a premier cancer care and research center in Northern […]
Read MoreJanuary 18, 2018
Practice increases clinical trial and advanced treatment options while gaining access to resources that improve operational efficiencies Philadelphia, Pa. (January 18, 2018) – Consultants in Medical Oncology and Hematology (CMOH), a premier provider of comprehensive medical oncology services throughout the Philadelphia region for nearly 30 years and a national leader in the development of patient and […]
Read MoreJanuary 5, 2018
Providers using iKnowMed certified EHR technology are eligible for Quality Performance bonus points under Merit-based Incentive Payment System The Woodlands, Texas (January 5, 2018) — McKesson Specialty Health, an industry leader in services and technologies that advance community-based healthcare, announced that iKnowMedSM electronic health record (EHR) (version 6.8) and iKnowMed Generation 2 EHR (version 3.0) […]
Read MoreDecember 4, 2017
19 abstracts on clinical research conducted by top affiliated investigators are scheduled for presentation The Woodlands, Texas (December 4, 2017) – At the 59th American Society of Hematology Annual Meeting and Exposition (ASH), leading investigators from The US Oncology Network and US Oncology Research will showcase detailed findings from 19 studies (four orals, 14 poster […]
Read MoreNovember 28, 2017
Dr. Akbari, a pioneer in breast cancer surgery, brings new line of treatment services to the clinic Fairfax, Va. (November 28, 2017) —Virginia Cancer Specialists (VCS) announced that Stephanie Akbari, MD, FACS, has joined the practice. VCS, a practice in The US Oncology Network, is a premier cancer care and research center in Northern Virginia […]
Read MoreNovember 3, 2017
Affiliation enhances care at both practices, expanding Maryland Oncology Hematology’s services into the Baltimore–Washington Metropolitan Area Columbia, Md. (November 3, 2017) — Maryland Oncology Hematology (MOH), a premier provider of community-based advanced cancer care services throughout the Maryland/Washington D.C. region and an affiliate of The US Oncology Network (The Network), announced that Frederick Oncology & […]
Read MoreNovember 2, 2017
Organization celebrates enrolling 70,000 patients to clinical trials, contributing to more than 70 FDA cancer therapy approvals The Woodlands, Texas (Nov. 2, 2017) — US Oncology Research is holding its 16th Annual Science Forum on November 2-3 in Dallas, an annual meeting that brings together more than 150 affiliated US Oncology Research physician researchers and […]
Read MoreSeptember 19, 2017
Mobile, Ala. (September 19, 2017) – Southern Cancer Center (SCC), a premier oncology clinic in Alabama and a practice in The US Oncology Network, is the first site in the world to open enrollment for a new clinical trial for newly diagnosed kidney cancer patients. This phase 3 clinical trial will look at various investigational […]
Read MoreSeptember 12, 2017
NERLYNXTM is a new treatment option for early-stage HER2+ breast cancer patients following adjuvant trastuzumab-based therapy in the extended adjuvant setting The Woodlands, Texas (September 12, 2017) — Early-stage breast cancer patients with HER2-positive tumors now have a promising new anti-HER2 treatment option in the extended adjuvant setting, thanks in large part to the efforts […]
Read MoreAugust 1, 2017
Eligible Patients to be Directed to Epizyme’s Ongoing Phase 2 Clinical Trial of Tazemetostat in Follicular Lymphoma and Diffuse Large B-cell Lymphoma THE WOODLANDS, Texas and CAMBRIDGE, Mass. (August 1, 2017) – Epizyme, Inc. (NASDAQ: EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, and US Oncology Research, one of the nation’s largest networks of […]
Read More
